Stock analysts at Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of ARS Pharmaceuticals in a report issued ...
Long gone are the days spent soaking up the sun outside. Now, we’re holed up indoors as much as possible, hiding from the chilly temperatures that will soon get even worse. And if you’re ...